600422 昆药集团
2024/09 - 九个月
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入5,457,455-2.73%7,703,1218,282,0638,253,5337,717,087
减:营业总成本5,001,893-3.17%7,153,0057,835,5157,829,0857,280,864
    其中:营业成本3,224,7114.61%4,250,5814,843,6904,844,7774,386,696
               财务费用16,81377.75%10,26938,30939,69236,121
               资产减值损失(14,671)6.21%(65,935)(67,592)(19,932)(22,331)
公允价值变动收益(176)-97.33%1,02610,673(960)(1,359)
投资收益12,246-20.75%17,3125,985150,64815,730
    其中:对联营企业和合营企业的投资收益(291)-30.23%(186)(255)(468)(7,092)
营业利润486,8472.18%568,496497,148634,047540,830
利润总额497,5064.35%563,620477,287631,289540,487
减:所得税费用106,99332.83%109,47791,827118,07578,304
净利润390,513-1.44%454,143385,459513,214462,183
减:非控股权益3,117-69.49%9,4632,2765,5465,326
股东净利润387,3960.36%444,680383,184507,668456,856

市场价值指针
每股收益 (元) *0.5120.47%0.5900.5100.6700.602
每股派息 (元) *----0.2000.1600.2700.230
每股净资产 (元) *7.3075.57%6.9896.5726.3085.870
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容